Menu

GMP Lab Publications on Inhaled Pharmaceuticals

Date: 7 March 2016 | Topic: Inhaled Pharmaceuticals

Developing medicines that are delivered via the pulmonary and nasal routes for the treatment of local and systemic diseases is challenging. While the demonstration of safety, potency and purity is a fundamental part of the marketing authorization process for all drugs, incorporation of a delivery device greatly increases the complexity of the drug development process.

PPD® Laboratories GMP lab has been supporting the respiratory community across the product development continuum for more than 17 years. We have depth of experience evaluating drug/device combinations and have authored several publications and presentations on the topic. Our scientists have chosen a few of their presentations and publications to share with you.

Please enter your contact information below to download these articles from PPD® Laboratories. Fields marked with * are required. Pharmaceutical Product Development, LLC and its affiliates (together “PPD”) will use the information you provide on this page for the purpose of sending you the requested articles and possibly following up with you. Important information on how PPD handles personal data and what rights you may have under data privacy laws are included within PPD’s Global Privacy Policy.


GMP Inhalation Assets Download

Contact Legal Notices Modern Slavery Transparency Statement Privacy Policy

© 2018 Pharmaceutical Product Development, LLC. All rights reserved.